ISPOR - Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

Full Text

Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

Abstract

Authors

E Priedane J Gagnon A Kumar

Back to Volume 20, Issue 9

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now